ConexiantVitamin K Refusal Rises in Newborns

Vitamin K refusal at birth nearly doubled from 3% to 5% between 2017-2024, affecting 199,571 of 5+ million newborns across 403 US hospitals. This reverses decades of protection against potentially fatal bleeding disorders in infants.

⚖️ PROFESSIONAL IMPACT

• Non-Hispanic White newborns showed highest refusal rates at 4%, with vaginal deliveries seeing more refusal than cesarean births—suggesting demographic and delivery-mode counseling gaps
• Trend began pre-pandemic, indicating vaccine hesitancy is broader phenomenon affecting all preventive interventions including routine newborn prophylaxis with 60+ years safety data
• Out-of-hospital births not captured in data, meaning actual refusal rates likely higher given home birth populations show elevated refusal patterns
• Study lacked data on parent reasoning for refusal, limiting ability to develop targeted interventions addressing specific concerns about injection pain or necessity

🎯 ACTION ITEMS

• Document vitamin K discussions and refusal in delivery notes to establish informed consent and liability protection
• Screen prenatal patients for vaccine hesitancy as proxy for prophylaxis refusal risk requiring enhanced counseling
• Train labor staff on addressing common parental concerns: injection pain, necessity, adverse effects with evidence-based responses
• Monitor for bleeding signs in refused cases with explicit parent education on vitamin K deficiency bleeding symptoms

More in Neonatology